Wockhardt LimitedNSE: WOCKPHARMA

Press Release May 04 2026

May 4, 2026 at 6:14 AM EDT · Issued by Wockhardt Limited

Filed with NSE · May 4, 2026 at 6:14 AM EDT · 8 pages · English

On 6ix: 6ix.com/news/press-release-may-04-2026-20

Release

Pursuant to Regulation 30 of the Listing Regulations, please find enclosed Press Release on theAudited Financial Results (Standalone and Consolidated) for the quarter and the financial yearended 31st March, 2026.

Wockhardt Limited on 6ix

Earlier from Wockhardt

Press Release Mar 30 2026Mar 30
Press Release Feb 10 2026Feb 10
Press Release Jan 27 2026Jan 27
Press Release Jan 07 2026Jan 7
Press Release Dec 31 2025Dec 31, 2025

Later from Wockhardt

Press Release May 28 2026May 27
Press Release May 30 2026May 30
Wockhardt Receives U.S. FDA Approval for ZAYNICH™ (cefepime and zidebactam), a Novel Intravenous Antibiotic for the Treatment of Adult Patients with Complicated Urinary Tract Infection Including PyelonephritisJun 1
Wockhardt Limited Press Release Aug 10 2026Aug 10

All Wockhardt news releases

Follow Wockhardt into a list and get an email when it puts out news.

Follow Wockhardt